InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Carola Elisabet Lemne. Director active across 1 company, notably IRLAB Therapeutics AB. Cumulatively, 2 reports have been published. History available since 1 July 2026. The latest transaction was filed on 30 June 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
2 of 2 declarations